Skip to main content

Advertisement

SpringerLink
Log in

Association of CYP1A1 Gene Polymorphism with Ischemic Stroke in South Indian Population

  • Published:
Translational Stroke Research Aims and scope Submit manuscript

Abstract

Stroke is a major cause of morbidity and mortality worldwide. Genetic and environmental factors are involved in the pathogenesis of stroke. Hypertension, diabetes mellitus, and cigarette smoking are the major risk factors, and smoking doubles the risk of ischemic stroke. Smoking cessation decreased the risk for ischemic stroke. CYP1A1 is the phase I metabolizing enzyme which plays a key role in metabolic activation of polycyclic aromatic hydrocarbons which are present in cigarette smoke and considered carcinogenic. So far, the association of CYP1A1 gene polymorphism with stroke has not been investigated in Indian population. So, the study is taken up to evaluate the association of this polymorphism with ischemic stroke in a South Indian population. We genotyped 215 ischemic stroke patients and 162 age-matched controls using polymerase chain reaction–restriction fragment length polymorphism. Statistical analysis showed that CYP1A1 “CC” genotype is associated with five times increased risk of ischemic stroke (odds ratio (OR) = 5.14; 95% confidence interval (95% CI) = 1.14–23.14, p = 0.01), while “TT” (OR = 0.78, 95% CI = 0.51–1.19, p = 0.25) and “TC” (OR = 1.04, 95% CI = 0.67–1.60, p = 0.85) genotypes were nonsignificant with the increased risk of stroke. T and C allele frequencies in stroke were 76.5% and 23.5% as against 81.8% and 18.2% in control group, respectively, thus, suggesting no statistically significant differences in the T (OR = 0.72, 95% CI = 0.50–1.03, p = 0.07) and C (OR = 1.37, 95% CI = 0.96–1.97, p = 0.07) allele frequencies between the two groups. The distribution of CYP1A1 genotypes and allelic frequency within the stroke subtypes showed a significant association of CC genotype only in intracranial large artery atherosclerosis (OR = 5.21, 95% CI = 1.03–26.38, p = 0.02) while other subtypes did not show any association. Further analysis of CYP1A1 genotypes in patients and control subjects with smoking habit also showed a similar trend. Hence, we conclude that the CYP1A1 CC genotype is associated with the increased risk of ischemic stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative. Lancet Neurol. 2004;3:391–3.

    Article  PubMed  Google Scholar 

  2. Goldstein LB, Adams R, Becher K, Furberg CD, Gorelick PB, Hademenos G, et al. Primary prevention of ischemic stroke: a statement for health care professionals from the Stroke Council of the American Heart Association. Circulation. 2001;103:162–82.

    Google Scholar 

  3. Warlow CP. Epidemilogy of stroke. Lancet. 1998; 352 (suppl 3)

  4. WHO. The world health report 2002: reducing risks, promoting health life. WHO, Geneva. 2002. http://www.who.int/whr/2002/en/.

  5. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298:789–94.

    Article  CAS  PubMed  Google Scholar 

  6. Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA. 1988;259:1025–9.

    Article  CAS  PubMed  Google Scholar 

  7. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Mason JE, Rosner B, et al. Smoking cessation and decreased risk of stroke in women. JAMA. 1993;269:232–6.

    Article  CAS  PubMed  Google Scholar 

  8. Penn and Snyder. Arteriosclerotic plaque development is ‘promoted’ by polynuclear aromatic hydrocarbons. Carcinogenesis. 1988;9:2185–9.

    Article  Google Scholar 

  9. Sharma P. Genes for ischaemic stroke: strategies for their detection. J Hypertens. 1996;14:277–85.

    Article  CAS  PubMed  Google Scholar 

  10. Nebert DW, Nelson DR, Coon MJ, Estabrook RW, Feyereisen R, Fujii-Kuriyama Y, et al. The P450 superfamily update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol. 1991;10:1–14.

    Article  CAS  PubMed  Google Scholar 

  11. Lanca V, Alcantara P, Braz-Nogueira J, Bicho MP. Cytochrome P450 1A1 (CYP1A1) T6325C polymorphism might modulate essential hypertension-associated stroke risk. Rev Port Cardiol. 2004;23(3):343–55.

    CAS  PubMed  Google Scholar 

  12. Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN. Cancer incidence, mortality and prevalance worldwide (1.0). Cancer Base no. 5. Lyon, France: IARC; 2001.

    Google Scholar 

  13. Szolnoki Z, Havasi V, Bene J, Komlosi K, Szoke D, Somogyvari F, et al. Endothelial nitric oxide synthase gene interactions and the risk of ischemic stroke. Acta Neurol Scand. 2005;111:29–33.

    Article  CAS  PubMed  Google Scholar 

  14. Casas JP, Hingorani AD, Bautista LE, Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18, 000 cases and 58, 000 controls. Arch Neurol. 2004;61:1652–61.

    Article  PubMed  Google Scholar 

  15. US Dept of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. US Department of Health and Human Services, Public Health Service Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. DHHS Publication (CDC) 89-8411

  16. US Dept of Health and Human Services. The health benefits of smoking cessation. A report of the Surgeon General. USDHHS, Centers for Disease Control. Office of Smoking and Health; 1990. DHHS Publication (CDC) 90–8416.

  17. Petersen DD, Mckinney CE, Ikeya K, Smith HH, Bale AE, Mc Bride OW, et al. Human CYP1A1 gene:cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet. 1991;48:720–5.

    CAS  PubMed  Google Scholar 

  18. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics. 1994;4:242–6.

    Article  CAS  PubMed  Google Scholar 

  19. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis. 1994;15:2961–3.

    Article  CAS  PubMed  Google Scholar 

  20. Kiyohara C, Hirohata T, Inusuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res. 1996;87:18–24.

    CAS  PubMed  Google Scholar 

  21. Kurahashi N, Sata F, Kasai S, Shibata T, Moriya K, Yamada H, et al. Maternal genetic polymorphisms in CYP1A1, GSTM1 and GSTT1 and the risk of hypospadias. Mol Hum Reprod. 2005;11:93–8.

    Article  CAS  PubMed  Google Scholar 

  22. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S. The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol. 1993;14:77–87.

    Article  CAS  PubMed  Google Scholar 

  23. Fritsche E, Schuppe HC, Dohr O, Ruzicka T, Gleichmann Abel J. Increased frequencies of cytochrome P4501A1 polymorphisms in infertile men. Andrologia. 1998;30:125–8.

    Article  CAS  PubMed  Google Scholar 

  24. Meschia JF. Subtyping in ischemic stroke genetic research. J Stroke Cerebrovasc Dis. 2002;11(5):208–19.

    Article  PubMed  Google Scholar 

  25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Definition and description of diabetes mellitus. Diabetes Care. 2009;32:S62–7.

    Article  Google Scholar 

  26. Lahari DK, Steve Bye, Nurenberger Jr JJ, Mario E, Hondes, Crisp M. A non-organic and non-enzymatic extraction method gives high yields of genomic DNA from whole blood samples than do nine other methods tested. J Biochem Biophys Methods. 1992;25:193–205.

    Article  Google Scholar 

  27. Cascorbi I, Brockmoller J, Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 1996;56:4965–9.

    CAS  PubMed  Google Scholar 

  28. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated Msp1 polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem. 1991;110:407–11.

    CAS  PubMed  Google Scholar 

  29. Kaul S, Sunitha P, Suvarna A, Meena AK, Uma M, Reddy JM. Subtypes of ischemic stroke in a metropolitan city of South India (one year data from a hospital based stroke registry). Neurol India. 2002;50(1):S8–15.

    PubMed  Google Scholar 

  30. Nebert DW. Role of genetics and drug metabolism in human cancer risk. Mutat Res. 1991;247:267–81.

    CAS  PubMed  Google Scholar 

  31. Babu KA, Reddy NG, Deendayal M, Kennedy S, Shivaji S. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and their relationship with advanced stages of endometriosis in South Indian women. Pharmacogenet Genomics. 2005;15(3):167–72.

    Article  CAS  PubMed  Google Scholar 

  32. Kawajiri K, Nakachi K, Imai k, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett. 1990;263:131–3.

    Article  CAS  PubMed  Google Scholar 

  33. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415–23.

    CAS  PubMed  Google Scholar 

  34. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, et al. Cytochrome P 450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493–7.

    Article  CAS  PubMed  Google Scholar 

  35. Jiang JG, Chen RJ, Xiao B, Yang S, Wang JN, Wang Y, et al. Regulation of endothelial nitric-oxide synthase activity through phosphorylation in response to epoxyeicosatrienoic acids. Prostaglandins Lipid Mediat. 2007;82:162–74.

    Article  CAS  Google Scholar 

  36. Wang Y, Wei X, Xiao X, Hui R, Card JW, Carey MA, et al. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. J Pharmacol Exp Ther. 2005;314:522–32.

    Article  CAS  PubMed  Google Scholar 

  37. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999;285:1276–9.

    Article  CAS  PubMed  Google Scholar 

  38. Davis BB, Thompson DA, Howard LL, Morisseau C, Hammock BD, Weiss RH. Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation. PNAS. 2002;99:2222–7.

    Article  CAS  PubMed  Google Scholar 

  39. Heizer ML, McKinney JS, Ellis EF. 14, 15-Epoxyeicosatrienoic acid inhibits platelet aggregation in mouse cerebral arterioles. Stroke. 1991;22:1389–93.

    CAS  PubMed  Google Scholar 

  40. Larsen BT, Gutterman DD, Hatoum OA. Emerging role of epoxyeicosatrienoic acids in coronary vascular function. Eur J Clin Invest. 2006;36:293.

    Article  CAS  PubMed  Google Scholar 

  41. Bhat VM, Cole JW, Sorkin JD, Wozniak MA, Malarcher AM, Giles WH, et al. Dose–response relationship between cigarette smoking and risk of ischemic stroke in young women. Stroke. 2008;39:2439–43.

    Article  PubMed  Google Scholar 

  42. Huriletemuer H, Zhang C, Niu G, Zhao S, Hurile H. Gene polymorphisms and related risk factors in Mongolian hypertensive stroke patients. Neurosciences. 2010;3:184–9.

    Google Scholar 

  43. Gang Zhu, Fang Liu, Hui Zhang, Xue Qin, Lei Li, He Zhiyi. CYP4F2 gene V433M polymorphism is associated with ischemic stroke in the male Northern Chinese Han population. Prog Neuro Psychopharmacol Biol Psychiatry. 2010;34(4):664–8.

    Article  Google Scholar 

  44. Zhang Laxi, Dinga Hu, Yan Jiangtao, Hui Rutai, Wang Wei, Kissling Grace E, et al. Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population. Pharmacogenet Genomics. 2008;18(1):45–51.

    Article  PubMed  Google Scholar 

  45. Moon Kyung-Suk, Lee Hye-Jung, Hong Seung-Heon, Kim Hyung-Min, Um Jae-Young. CYP1A1 and GSTM1/T1 genetic variation in predicting risk for cerebral infarction. J Mol Neurosci. 2007;32:155–9.

    Article  CAS  PubMed  Google Scholar 

  46. Funk M, Freitag R, Endler G, Lalouschek W, Lang W, Mannhalter C, et al. Influence of cytochrome P450 2C9*2 and 2C9*3 variants on the risk of ischemic stroke: a cross-sectional case–control study. Clin Chem. 2005;51:1716–8.

    Article  CAS  PubMed  Google Scholar 

  47. Nan Song, Wen Tan, Deyin Xing, Dongxin Lin. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case–control study in China. Carcinogenesis. 2001;22:11–6.

    Article  Google Scholar 

  48. Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res. 1995;55:3757–8.

    CAS  PubMed  Google Scholar 

  49. Gudimella Tirumala Vani, Navgire Mukesh, Badabagni Siva Prasad, et al. Association of CYP1A1*2A polymorphism with male infertility in Indian population. Clin Chim Acta. 2009;410:43–7.

    Article  Google Scholar 

  50. Luria MH, Erel J, Sapoznikov D, Gotsman MD. Cardiovascular risk factor clustering and ratio of total cholesterol to high-density lipoprotein cholesterol in angiographically documented coronary artery disease. Am J Cardiol. 1991;67:31–6.

    Article  CAS  PubMed  Google Scholar 

  51. Taioli E, Ford J, Trachman J, et al. Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis. 1998;19:813–7.

    Article  CAS  PubMed  Google Scholar 

  52. Slattery Martha L, Samowtiz W, Ma K, Murtaugh M, Sweeney C, Levin TR, et al. CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol. 2004;160:842–52.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the Chairman of Bhagwan Mahavir Hospital & Research Center and the Registrar, MGNIRSA, Hyderabad, India, for extending all the facilities to carry out the study. We would also like to thank the patients and volunteers who have given their consent and participated in the study.

Author information

Authors and Affiliations

  1. Bhagwan Mahavir Medical Research Centre, A.C. Guards, Hyderabad, 500 004, Andhra Pradesh, India

    Shehnaz Sultana & Pardhananda Reddy Penagaluru

  2. Hospital for Genetics Diseases, Osmania University, Begumpet, Hyderabad, 500016, Andhra Pradesh, India

    Venkata Karunakar Kolla, Vidyullatha Peddireddy, Yasovanthi Jeedigunta & Usha Rani Penagaluru

  3. Department of Medicine, Bhagwan Mahavir Medical Research Centre, A.C. Guards, Hyderabad, 500 004, Andhra Pradesh, India

    Pranay K. Penagaluru & Sindhu Joshi

Authors
  1. Shehnaz Sultana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Venkata Karunakar Kolla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vidyullatha Peddireddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasovanthi Jeedigunta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pranay K. Penagaluru
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sindhu Joshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Usha Rani Penagaluru
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pardhananda Reddy Penagaluru
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pardhananda Reddy Penagaluru.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sultana, S., Kolla, V.K., Peddireddy, V. et al. Association of CYP1A1 Gene Polymorphism with Ischemic Stroke in South Indian Population. Transl. Stroke Res. 2, 26–32 (2011). https://doi.org/10.1007/s12975-010-0059-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12975-010-0059-8

Keywords

Search

Navigation